Cetuximab in locally advanced head-and-neck cancer: Defining the population

Current Oncology

Volumn 17, Issue 4, 2010, Pages 48-51

  Ho, Cheryl ^a  

^a Vancouver Cancer Center   (Canada)

Author keywords

Cetuximab; Cisplatin; Head and neck squamous cell carcinoma; Locally advanced; Radiotherapy

Indexed keywords

CETUXIMAB; CISPLATIN; PANITUMUMAB;

ADVANCED CANCER; ARTICLE; CANADA; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLOMBIA; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; HEAD AND NECK CANCER; HUMAN; OVERALL SURVIVAL; PATIENT SELECTION; PRACTICE GUIDELINE; PROGRESSION FREE SURVIVAL; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION;

EID: 78149448832     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i4.696     Document Type: Article

References (7)

1. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
2. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21-8.
3. Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116-27.
4. Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R, and The Head and Neck Cancer Disease Site Group. Epidermal growth factor receptor targeted therapy in stages iii and iv head and neck cancer. Curr Oncol 2010;17:37-48.
5. National Institute for Health and Clinical Excellence (nice). Cetuximab for the Treatment of Locally Advanced Squamous Cell Cancer of the Head and Neck.Nice Technology Appraisal Guidance 145. London, U.K.: nice; 2008.
6. BC Cancer Agency. bcca Protocol Summary for Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Vancouver: BC Cancer Agency; 2010. [Available online at: www. bccancer.bc.ca/NR/rdonlyres/B6382FB0-629C-4F1C-9F3D- 24E0D09C456A/44569/UHNLACETRT_Protocol_1Apr2010. pdf; cited June 11, 2010]
7. Pignon JP, Le Maître A, Maillard E, Bourhis J On behalf of the mach-nc Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (mach-nc): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14.